Plevris, N., Jenkinson, P. W., Chuah, C. S., Lyons, M., Merchant, L. M., Pattenden, R. J., . . . Lees, C. W. (2019). Association of trough vedolizumab levels with clinical, biological and endoscopic outcomes during maintenance therapy in inflammatory bowel disease. Frontline Gastroenterol.
Chicago Style CitationPlevris, Nikolas, Philip W. Jenkinson, Cher S. Chuah, Mathew Lyons, Lynne M. Merchant, Rebecca J. Pattenden, Ian D. Arnott, Gareth R. Jones, i Charlie W. Lees. "Association of Trough Vedolizumab Levels With Clinical, Biological and Endoscopic Outcomes During Maintenance Therapy in Inflammatory Bowel Disease." Frontline Gastroenterol 2019.
Cita MLAPlevris, Nikolas, et al. "Association of Trough Vedolizumab Levels With Clinical, Biological and Endoscopic Outcomes During Maintenance Therapy in Inflammatory Bowel Disease." Frontline Gastroenterol 2019.